Bionova Scientific

Executive Summary

Bionova Scientific is a US-based biologics Contract Development and Manufacturing Organization (CDMO) founded in 2017 and headquartered in Fremont, California. The company specializes in providing comprehensive development and GMP manufacturing services for therapeutic proteins, including monoclonal antibodies, using mammalian cell culture processes. By accelerating client programs from early development through commercial manufacturing, Bionova Scientific serves as a strategic partner for biotech and pharmaceutical companies seeking to outsource biologics production. With the growing demand for biologics and cell therapies, the CDMO market is expanding, and Bionova is well-positioned to capture a share of this growth through its technical expertise and flexible service offerings. However, as a private company with limited public disclosure, its financial performance and pipeline visibility are low, which moderates conviction.

Upcoming Catalysts (preview)

• TBDCapacity Expansion Announcement60% success
• TBDStrategic Partnership with Major Pharma40% success
• TBDFDA Approval of Client Product Using Bionova's Manufacturing30% success